Kakamega County, Kenya, Sept. 26, 2022 (GLOBE NEWSWIRE) —
Immunify.Life, a transformative blockchain-based healthcare ecosystem, in partnership with Masinde Muliro University of Science and Technology (MMUST) – the premier science, technology, and innovation university in Kenya – has completed groundwork for a large-scale HIV/AIDS treatment outcomes study that is now formally launched. As part of the study, the Immunify.Life data capture and processing platform will be used to help empower patients, communities, and entire countries using token rewards that can improve medical regimen adherence rates in previously lapsed HIV/AIDS patients.
The HIV/AIDS treatment outcomes study is an elegant application of the Immunify.Life technology, and the results from the study will contribute to the future Strategic Direction on HIV treatment in Kenya
According to Department of Health coordinators in Kakamega County, there were more than 1,000 patients with high viral loads in July, which may be indicative of treatment failure. This means that this study is not only necessary, but also timely. Kenya has one of the world’s largest populations of people living with HIV/AIDs and approximately 30% are not taking treatment. Furthermore, 42% of all new HIV infections in Kenya are adolescents and young adults.
Immunify.Life CEO Guy Newing commented on the study by saying: “The technology that we are using at Immunify.Life is designed to address the challenges of HIV and AIDS, tuberculosis, and vaccination programmes. Blockchain technology is the cutting edge new frontier technology that will revolutionize healthcare in Africa.”
Dr. Charles Mutai, Professor at the Medical School at MMUST, said: “Our Vice Chancellor is keen on strengthening research capacity and has championed the setting up of research teams to write proposals in different areas. This project will therefore receive the required administrative support. We expect that this project can be used…
